• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BCAB

BCAB

BioAtla, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.40

-0.13 (-3.68%)

Rating:C

Company Profile

CEO

Jay Short

IPO Date

2020-12-16

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.58

Prev. Close

$3.53

Day Low

$3.26

Day High

$3.58

52W Low

$3.26

52W High

$71.50

Market Cap

$0.00B

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

5

Avg Positive

38.8%

Avg Negative

6.0%

Avg Neutral

55.0%

News Feed

BioAtla Announces Second Quarter 2021 Financial Results And Provides Clinical Update

PRNewsWire·8/13/2021·↑ positive

BioAtla Announces First Quarter 2021 Financial Results And Provides Business Update

PRNewsWire·5/12/2021·↑ positive

BioAtla: Intriguing Science, New IPO, A Name To Watch

Seeking Alpha·2/7/2021·↓ negative

BioAtla Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

PRNewsWire·12/18/2020·↓ negative

BioAtla Announces Pricing of Initial Public Offering

PRNewsWire·12/15/2020·↑ positive